Changes in Depression and Anxiety in a Randomized, Double-blind, Placebo-controlled Study of Galcanezumab in Adults with Treatment-resistant Migraine: Results from the CONQUER Study

被引:0
|
作者
Maizels, Morris [1 ]
Buse, Dawn C. [2 ]
Jedynak, Jakub [3 ]
Hand, Austin L. [4 ]
Ford, Janet [3 ]
Detke, Holland [3 ]
机构
[1] Providence St Joseph Hlth, Renton, WA USA
[2] Yeshiva Univ, Albert Einstein Coll Med, New York, NY 10033 USA
[3] Eli Lilly & Co, Indianapolis, IN 46285 USA
[4] IQVIA, Durham, NC USA
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
1383
引用
收藏
页数:3
相关论文
共 50 条
  • [21] Double-blind randomized placebo-controlled study of homoeopathic prophylaxis of migraine
    Whitmarsh, TE
    ColestonShields, DM
    Steiner, TJ
    CEPHALALGIA, 1997, 17 (05) : 600 - 604
  • [22] Oxcarbazepine in migraine headache - A double-blind, randomized, placebo-controlled study
    Silberstein, S.
    Saper, J.
    Berenson, F.
    Somogyi, M.
    McCague, K.
    D'Souza, J.
    NEUROLOGY, 2008, 70 (07) : 548 - 555
  • [23] Transcranial direct current stimulation in treatment resistant depression: A randomized double-blind, placebo-controlled study
    Palm, U.
    Schiller, C.
    Fintescu, Z.
    Obermeier, M.
    Keeser, D.
    Reisinger, E.
    Pogarell, O.
    Nitsche, M. A.
    Moeller, H-J
    Padberg, F.
    BRAIN STIMULATION, 2012, 5 (03) : 242 - 251
  • [24] DOUBLE-BLIND, PLACEBO-CONTROLLED, CROSSOVER STUDY OF LAMOTRIGINE IN TREATMENT-RESISTANT PARTIAL SEIZURES
    SCHAPEL, GJ
    BERAN, RG
    VAJDA, FJE
    BERKOVIC, SF
    MASHFORD, ML
    DUNAGAN, FM
    YUEN, WC
    DAVIES, G
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1993, 56 (05): : 448 - 453
  • [25] Almotriptan for acute treatment of migraine: a randomized, double-blind, placebo-controlled study in Korea
    Chung, C. S.
    Park, K. Y.
    Moon, H. S.
    Joo, S. A.
    Song, K. S.
    Kim, J. A.
    CEPHALALGIA, 2006, 26 (11) : 1392 - 1392
  • [26] Botulinum toxin A in the prophylactic treatment of migraine - a randomized, double-blind, placebo-controlled study
    Evers, S
    Vollmer-Haase, J
    Schwaag, S
    Rahmann, A
    Husstedt, IW
    Frese, A
    CEPHALALGIA, 2004, 24 (10) : 838 - 843
  • [27] Double-blind, placebo-controlled, crossover study of lamotrigine in treatment-resistant generalised epilepsy
    Beran, RG
    Berkovic, SF
    Dunagan, FM
    Vajda, FJE
    Danta, G
    Black, AB
    Mackenzie, R
    EPILEPSIA, 1998, 39 (12) : 1329 - 1333
  • [28] Antidepressant augmentation with metyrapone for treatment-resistant depression (the ADD study): a double-blind, randomised, placebo-controlled trial
    McAllister-Williams, R. Hamish
    Anderson, Ian M.
    Finkelmeyer, Andreas
    Gallagher, Peter
    Grunze, Heinz C. R.
    Haddad, Peter M.
    Hughes, Tom
    Lloyd, Adrian J.
    Mamasoula, Chrysovalanto
    McColl, Elaine
    Pearce, Simon
    Siddiqi, Najma
    Sinha, Baxi N. P.
    Steen, Nick
    Wainwright, June
    Winter, Fiona H.
    Ferrier, I. Nicol
    Watson, Stuart
    LANCET PSYCHIATRY, 2016, 3 (02): : 117 - 127
  • [29] Onset of efficacy of ketamine in treatment-resistant depression: a double-blind, randomised, placebo-controlled, dose frequency study
    Singh, J.
    Fedgchin, M.
    Daly, E.
    De Boer, P.
    Cooper, K.
    Lim, P.
    Pinter, C.
    Murrough, J.
    Sanacora, G.
    Shelton, R.
    Kurian, B.
    Winokur, A.
    Fava, M.
    Manji, H.
    Drevets, W.
    Van Nueten, L.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S387 - S388
  • [30] Kava in the Treatment of Generalized Anxiety Disorder A Double-Blind, Randomized, Placebo-Controlled Study
    Sarris, Jerome
    Stough, Con
    Bousman, Chad A.
    Wahid, Zahra T.
    Murray, Greg
    Teschke, Rolf
    Savage, Karen M.
    Dowell, Ashley
    Ng, Chee
    Schweitzer, Isaac
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2013, 33 (05) : 643 - 648